Baseline and Dynamic Changes in Skeletal Muscle Mass As Predictive Biomarkers in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab: Predictive Value of Sarcopenia in MRCC. Radiol Oncol 2025, 59 (4), 624-634.